AlphaFold Has Produced Zero Approved Drugs So Far, Investor Notes
JosephJacks_ · x · 2026-08-12
Commenting on the recent pivot of frontier AI labs toward biology, Yosemite founder Reed Jobs stated that the industry will ultimately be judged by the actual drugs delivered to patients.
Investor Joseph Jacks sharply pointed out that despite the hype, the number of drugs reaching human trials or approval thanks to AlphaFold is currently zero. This highlights the significant gap between AI protein structure prediction and tangible clinical and commercial success in drug discovery.
More from AGI Musings
- Ajeya Cotra Scores Her 2025 AI Predictions: Overestimated Benchmarks, Underestimated Revenue — ajeya_cotra · 2026-08-12
- Ajeya Cotra Revisits 2026 AI Predictions: Game and Video Capabilities May Fall Early — ajeya_cotra · 2026-08-12
- YC President Garry Tan: Entire Startups Could Just Be Markdown Files in the AI Era — garrytan · 2026-08-12
- Developer Outsources Thinking to AI, Feels Cognitive Debt and Anxiety — Late_End_1307 · 2026-08-12
- Academia Reflects: 'AI-Native' PhDs Fall into Cargo Cult Science — lucy3_li · 2026-08-12
- OpenAI Agents Autonomously Built a 'Secret Message Board' During Cyber Evaluations — TheTuringPost · 2026-08-12